These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Iohexol for cervical myelography via C1-C2 puncture: study of efficacy and adverse reactions. Latchaw RE; Sackett JF; Turski PA; Shaw DD AJNR Am J Neuroradiol; 1985; 6(6):927-30. PubMed ID: 3934931 [TBL] [Abstract][Full Text] [Related]
8. Documentation of a new contrast medium for the subarachnoid space. Demands, design and results from the first multicentre trial with iohexol. Grönneröd TA; Eldevik OP; Hindmarsh T; Kendall B; Nakstad PH Acta Radiol Diagn (Stockh); 1983; 24(6):487-91. PubMed ID: 6367366 [TBL] [Abstract][Full Text] [Related]
18. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium. Shaw DD; Bach-Gansmo T; Dahlstrom K Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616 [TBL] [Abstract][Full Text] [Related]
19. Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study. Nakstad P; Helgetveit A; Aaserud O; Ganes T; Nyberg-Hansen R Neuroradiology; 1984; 26(6):479-84. PubMed ID: 6390248 [TBL] [Abstract][Full Text] [Related]
20. Iohexol vs. metrizamide: study of efficacy and morbidity in cervical myelography. Latchaw RE; Hirsch WL; Horton JA; Bissonette D; Shaw DD AJNR Am J Neuroradiol; 1985; 6(6):931-3. PubMed ID: 3934932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]